Skip to content
Wenlo
Sign in

News

Market news

Press releases, earnings reports, SEC filings and insider trades from US large-cap companies, and PR Newswire releases from US-listed companies, newest first, with short AI summaries.

  • Press releaseLLYEli Lilly and Company

    Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial

    Eli Lilly and Company announced positive topline results from the TRANSCEND-T2D-2 Phase 3 trial on October 28, 2026. The trial compared retatrutide with Ozempic 2 mg in adults with type 2 diabetes over 80 weeks. Participants taking retatrutide achieved an average A1C reduction of 2.2% versus 1.8% for Ozempic, and lost an average of 44.3 lbs to 47.4 lbs compared to 20.9 lbs for Ozempic.

    Source: PR NewswireIndustry HEAIndustry MTCIndustry PHASubject TRI

  • Press releaseLIILennox International Inc.

    Lennox Reports 2026 Third Quarter Earnings Results

    Source: PR NewswireIndustry UTIIndustry CSTIndustry HOUIndustry OILIndustry HVASubject ERN

  • Press releaseSWSmurfit WestRock Plc

    Tony Smurfit, President and CEO, commented:

    Smurfit WestRock Plc reported financial results for the third quarter ended September 30, 2026, announcing net sales of $8,161 million and net income of $219 million. The company reported adjusted EBITDA of $1,205 million and approved a quarterly dividend of $0.4523 per ordinary share. President and CEO Tony Smurfit noted the resilient performance amidst cost inflation and lower converting volumes.

    Source: SEC EDGAR

  • Press releaseAONAon plc Class A

    News from Aon

    Aon plc reported third-quarter 2026 financial results, announcing total revenue of $4.1 billion, representing a 3% increase compared to the prior-year period. Organic revenue grew by 6%, driven by broad-based strength across solution lines including Commercial Risk and Reinsurance. Diluted earnings per share were $2.23, while adjusted diluted earnings per share reached $3.36.

    Source: SEC EDGAR

  • 8-KBSXBoston Scientific Corp.

    Current report

    Boston Scientific Corp. filed a current report on October 28, 2026, announcing its financial results for the third quarter ended September 30, 2026. The company furnished a copy of its press release as an exhibit to the filing.

    Source: SEC EDGAR

  • Press releaseDINOHF Sinclair Corporation

    HF Sinclair Reports 2026 Third Quarter Results and Announces Regular Cash Dividend

    HF Sinclair Corporation reported third-quarter 2026 net income attributable to stockholders of $2,015 million, or $11.38 per diluted share, alongside adjusted net income of $2,079 million, or $11.75 per diluted share. The company returned $572 million to stockholders through dividends and share repurchases, and declared a regular quarterly cash dividend of $0.525 per share. Additionally, the company announced the appointment of Steve Ledbetter as Chief Executive Officer and President, effective January 1, 2027.

    Source: SEC EDGAR

  • Press releaseGLDGGoldMining Inc.

    GoldMining Commences Pre-Feasibility Study and Begins Infill Drilling with Three Drills at the São Jorge Project, Brazil

    Source: PR NewswireIndustry MNGIndustry OTCIndustry MINIndustry PRM

  • Press releaseGPUSHyperscale Data Inc.

    Hyperscale Data Engages Newmark to Arrange Non-Dilutive Long-Term Debt Financing for the Michigan AI Data Center

    Source: PR NewswireIndustry AFIIndustry CPRSubject FNC

  • Press releaseBSXBoston Scientific Corporation

    Boston Scientific announces results for third quarter 2026

    Boston Scientific Corporation announced net sales of $5.138 billion for the third quarter of 2026, representing a 1.5 percent increase compared to the prior year period. The company reported GAAP net income of $582 million, or $0.40 per share, and an adjusted EPS of $0.73. The results were released on October 28, 2026, alongside segment growth figures and regulatory updates for the company's medical technology portfolio.

    Source: PR NewswireIndustry HEAIndustry MTCIndustry MEQSubject ERN

  • Press releasePBProsperity Bancshares, Inc.

    PROSPERITY BANCSHARES, INC.® REPORTS THIRD QUARTER 2026 EARNINGS

    Source: PR NewswireIndustry FINSubject ERN

  • Press releaseAONAon Corporation

    Aon Reports Third-Quarter 2026 Results

    Source: PR NewswireIndustry FINIndustry DTAIndustry CPRSubject ERN

  • Press releaseGLDGGoldMining Inc.

    GoldMining Commences Pre-Feasibility Study and Begins Infill Drilling with Three Drills at the São Jorge Project, Brazil

    Source: PR NewswireIndustry MNGIndustry OTCIndustry MINIndustry PRM

  • 10-QGEHCGE HealthCare Technologies Inc.

    Quarterly report

    GE HealthCare Technologies Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. Total revenues for the third quarter were $5,513 million, representing a 7.2% increase compared to the same period in 2025. Net income attributable to GE HealthCare for the quarter was $615 million.

    Source: SEC EDGAR

  • Press releaseGEHCGE HealthCare Technologies Inc.

    GE HealthCare reports third quarter 2026 financial results

    GE HealthCare Technologies Inc. announced its third quarter 2026 financial results, reporting revenues of $5.5 billion and net income attributable to GE HealthCare of $615 million. The company also raised its full-year 2026 guidance, driven by strong top-line growth and margin expansion. Additionally, GE HealthCare announced that Jeannette Bankes will resign as President and CEO of Patient Care Solutions, with Neal Sandy succeeding her starting November 16, 2026.

    Source: SEC EDGAR

  • 10-QBIIBBiogen Inc.

    Quarterly report

    Biogen Inc. filed its quarterly report for the period ended September 30, 2026. The filing provides a comprehensive discussion of financial condition, market risks, legal proceedings, and internal controls. No share repurchases were made during the third quarter of 2026.

    Source: SEC EDGAR

  • 10-QGEVGE Vernova Inc.

    Quarterly report

    GE Vernova Inc. filed its quarterly report for the period ended September 30, 2026, reporting total revenues of $12.6 billion and net income of $1.3 billion for the third quarter. Diluted earnings per share were $4.81, while free cash flow reached $15.3 billion for the first nine months of the year. Additionally, the company announced an increase in its share repurchase authorization to $20.0 billion.

    Source: SEC EDGAR

  • Press releaseTELTE Connectivity plc

    TE Connectivity delivers 12% sales increase and over 20% EPS growth in fiscal fourth quarter

    TE Connectivity plc announced its fourth quarter and full year fiscal 2026 results, reporting record net sales of $5.3 billion for the quarter—a 12% increase year over year—and full year net sales of $19.9 billion, up 15%. Fourth quarter GAAP diluted earnings per share from continuing operations reached $3.10, representing a 39% increase from the same period last year. The company also reported full year GAAP EPS of $11.07 and provided an outlook for the first quarter of fiscal 2027 expecting sales of approximately $5.35 billion.

    Source: SEC EDGAR

  • 8-KGEVGE Vernova Inc.

    Current report

    GE Vernova Inc. filed a current report on October 28, 2026, announcing its third-quarter 2026 financial results. The results were made available on the company's investor relations website.

    Source: SEC EDGAR

  • Press releaseUUUUEnergy Fuels Inc.

    Energy Fuels Announces Conference Call and Webcast Details for Q3-2026 Earnings

    Source: PR NewswireIndustry MNGIndustry OILSubject CCA

  • Press releaseUUUUEnergy Fuels Inc.

    Energy Fuels Announces Conference Call and Webcast Details for Q3-2026 Earnings

    Source: PR NewswireIndustry MNGIndustry OILSubject CCA

  • Press releaseOTISOtis Worldwide Corporation

    OTIS REPORTS THIRD QUARTER 2026 RESULTS

    Source: PR NewswireIndustry MACIndustry MNGSubject ERN

  • Press releaseBIIBBiogen Inc.

    Cambridge, Mass. – October 28, 2026

    Biogen Inc. reported third quarter 2026 total revenue of $2.8 billion, representing an 11% increase year-over-year. The company posted a GAAP diluted loss per share of $(0.14) and a Non-GAAP diluted EPS of $2.62. Additionally, Biogen raised the lower end of its full year 2026 Non-GAAP diluted EPS guidance range to $12.20 to $13.00.

    Source: SEC EDGAR

  • Press releaseAVTRAvantor and Financial News

    Avantor® Reports Third Quarter 2026 Results

    Source: PR NewswireIndustry MFGIndustry CPRIndustry MEQIndustry MTCIndustry HEAIndustry MNGSubject ERN

  • Press releaseOTISOtis Worldwide Corporation

    OTIS REPORTS THIRD QUARTER 2026 RESULTS

    Otis Worldwide Corporation reported third quarter 2026 net sales of $3.9 billion, representing a 6% increase compared to the prior year. GAAP earnings per share rose 14% to $1.08, while adjusted earnings per share were flat at $1.05. The company maintained its full-year outlook for 2026, projecting net sales between $15.1 and $15.3 billion.

    Source: SEC EDGAR

  • Press releasePATKPatrick Industries, Inc.

    Patrick Industries, Inc. Reaffirms Merger Agreement with LCI Industries

    Source: PR NewswireIndustry TRNIndustry CSTIndustry FRNIndustry HOUSubject TNM

Press releases and filings from SEC EDGAR and PR Newswire. AI summaries can miss details: read the original before you act. Not investment advice.